Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% | |
natural killer cell | 3 studies | 26% ± 12% | |
dendritic cell | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of VPS16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1934.43 | 1445 / 1445 | 100% | 23.97 | 183 / 183 |
pancreas | 100% | 1692.70 | 328 / 328 | 100% | 29.39 | 178 / 178 |
skin | 100% | 2076.29 | 1809 / 1809 | 100% | 44.23 | 472 / 472 |
stomach | 100% | 1859.61 | 359 / 359 | 100% | 26.05 | 286 / 286 |
thymus | 100% | 3230.17 | 653 / 653 | 100% | 31.97 | 605 / 605 |
uterus | 100% | 2880.23 | 170 / 170 | 100% | 40.93 | 459 / 459 |
lung | 100% | 2456.11 | 578 / 578 | 100% | 28.55 | 1154 / 1155 |
breast | 100% | 2425.33 | 459 / 459 | 100% | 36.14 | 1117 / 1118 |
prostate | 100% | 2711.48 | 245 / 245 | 100% | 32.68 | 501 / 502 |
kidney | 100% | 1963.39 | 89 / 89 | 100% | 26.42 | 899 / 901 |
liver | 100% | 1238.44 | 226 / 226 | 100% | 23.45 | 405 / 406 |
adrenal gland | 100% | 2067.51 | 258 / 258 | 100% | 28.40 | 229 / 230 |
intestine | 100% | 2265.98 | 966 / 966 | 99% | 28.02 | 524 / 527 |
bladder | 100% | 2247.67 | 21 / 21 | 99% | 34.89 | 501 / 504 |
ovary | 100% | 2411.82 | 180 / 180 | 99% | 26.06 | 427 / 430 |
brain | 99% | 1752.56 | 2620 / 2642 | 100% | 42.12 | 705 / 705 |
adipose | 100% | 2360.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 32.44 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 39.52 | 29 / 29 |
spleen | 100% | 3296.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.40 | 1 / 1 |
muscle | 100% | 1252.94 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1723.59 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2123.97 | 920 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1139.65 | 850 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006886 | Biological process | intracellular protein transport |
GO_0016197 | Biological process | endosomal transport |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0042144 | Biological process | vacuole fusion, non-autophagic |
GO_0035542 | Biological process | regulation of SNARE complex assembly |
GO_0097352 | Biological process | autophagosome maturation |
GO_0034058 | Biological process | endosomal vesicle fusion |
GO_0033263 | Cellular component | CORVET complex |
GO_0031902 | Cellular component | late endosome membrane |
GO_0030897 | Cellular component | HOPS complex |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0005770 | Cellular component | late endosome |
GO_0005776 | Cellular component | autophagosome |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | VPS16 |
Protein name | VPS16 core subunit of CORVET and HOPS complexes VPS16 protein Vacuolar protein sorting-associated protein 16 homolog (hVPS16) Vacuolar protein sorting-associated protein 16 homolog |
Synonyms | |
Description | FUNCTION: Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act as a core component of the putative HOPS and CORVET endosomal tethering complexes which are proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations . Required for recruitment of VPS33A to the HOPS complex . Required for fusion of endosomes and autophagosomes with lysosomes; the function is dependent on its association with VPS33A but not VPS33B . The function in autophagosome-lysosome fusion implicates STX17 but not UVRAG . . |
Accessions | ENST00000417508.1 Q5JUB0 Q9H269 Q6GMQ7 A1A4H0 ENST00000453689.5 Q5JUA9 ENST00000380469.7 [Q9H269-2] ENST00000380445.8 [Q9H269-1] |